Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease myocardial infarction
Symptom C0796095|c syndrome
Sentences 21
PubMedID- 23411742 We conclude that prevalence of metabolic syndrome in patients with premature myocardial infarction is high; high tg is the most common component of metabolic syndrome.
PubMedID- 20488312 Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries.
PubMedID- 25789257 This finding might partly explain the higher risk of development of heart failure following acute myocardial infarction in patients with metabolic syndrome.
PubMedID- 24020829 Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome.
PubMedID- 20811489 We sought to determine and compare the prevalence of the metabolic syndrome (ms) in patients with acute myocardial infarction (ami) utilizing the new international diabetes federation (idf) definition with the older national cholesterol education program (ncep) definition.
PubMedID- 21159478 Acute inferior myocardial infarction with nephrotic syndrome.
PubMedID- 21646744 Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome.
PubMedID- 23635324 In the cardiovascular inflammation reduction trial (cirt) low dose methotrexate (target dose 20 mg/week) is tested for reduction of major cvd events among post-myocardial infarction patients with diabetes or metabolic syndrome.
PubMedID- 22701134 Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein b on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention.
PubMedID- 25563711 Conclusions: this prospective observational cohort trial demonstrated that chronic ace-i therapy was an independent predictor for reduced periprocedural myocardial infarction among patients with metabolic syndrome who underwent elective coronary intervention.
PubMedID- 21757819 Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms).
PubMedID- 23715346 The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay.
PubMedID- 21428179 Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction.
PubMedID- 22240598 Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction.
PubMedID- 21129152 It also reduced the risk of myocardial infarction in patients with severe metabolic syndrome by 56% (8 year follow-up) and the development of type 2 diabetes by almost half (2 and 5 year follow-up) .
PubMedID- 20509277 Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction).
PubMedID- 19356813 Obesity and the metabolic syndrome in patients with acute myocardial infarction.
PubMedID- 22263382 Metabolic syndrome and outcome in patients with acute myocardial infarction.
PubMedID- 22971940 Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction.
PubMedID- 23934969 Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des).
PubMedID- 20890426 We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes.

Page: 1